XML 100 R91.htm IDEA: XBRL DOCUMENT v3.25.3
Subsequent Events - Additional Information (Details)
$ / shares in Units, $ in Millions
 9 Months Ended
Oct. 08, 2025
Oct. 07, 2025
USD ($)
NonTradableContingentValueRightCvrPerShare
$ / shares
Aug. 06, 2025
USD ($)
Sep. 30, 2025
Dec. 31, 2020
After First Anniversary of Closing Date but on or Prior to Second Anniversary of Closing Date          
Subsequent Event [Line Items]          
Debt instrument effective interest rate         8.25%
scPharmaceuticals Inc. | Subsequent Event          
Subsequent Event [Line Items]          
Effective date of acquisition   Oct. 07, 2025      
Acquisition price per share in cash | $ / shares   $ 5.35      
Non-tradable contingent value right ("CVR") per share | NonTradableContingentValueRightCvrPerShare   1      
Amount per CVR in cash upon achievement of certain regulatory and net sales milestones | $ / shares   $ 1      
Equity value   $ 303.8      
Deal value   363.5      
Aggregate repayment and buyout amount   $ 82.6      
scPharmaceuticals Inc. | Maximum | Subsequent Event          
Subsequent Event [Line Items]          
Consideration per share in cash | $ / shares   $ 6.35      
Blackstone Credit Facility          
Subsequent Event [Line Items]          
Interest rate description       The term loans thereunder bear interest at a rate per annum equal to, (i) in the case of a Base Rate Loan, the greatest of (a) the prime rate in effect on such day, (b) the federal funds rate in effect on such day plus 0.5%, (c) Adjusted Term SOFR (defined below) for a one-month’s tenor in effect on such day plus 1%, and (d) 3.0% plus a margin of 3.75%, or (ii) in the case of a SOFR Loan, the one, three or six month term SOFR (at the Company’s election), subject to a 2.00% floor (the “Adjusted Term SOFR”), plus a margin of 4.75%. In addition, upon the occurrence and continuation of an event of default under the Amended Credit Agreement, interest on the term loans accrues at the applicable rate plus 2.00% per annum. As of September 30, 2025, the effective interest rate is 9.62% per annum. Interest is paid quarterly or, if the Company elects 1-month SOFR, monthly. The interest rate margin increases to 4.00% in the case of a Base Rate Loan and 5.00% in the case of a SOFR Loan at any time the Company’s ratio of indebtedness to adjusted EBITDA (measured on a trailing four quarter basis) is greater than or equal to 5.00:1.00 as of the most recent fiscal quarter for which the Company has delivered financial statements. Term loans under the Amended Credit Agreement are funded net of an upfront fee payable by the Company. The Company shall pay the delayed draw term loan lenders a ticking fee at a rate per annum equal to 1.00% of the daily unused portion of the delayed draw term loan commitments beginning on the one year anniversary of the agreement through the end of the delayed draw commitment period, payable quarterly in arrears.All term loans under the Blackstone Credit Facility, as well as any accrued and unpaid interest and fees, are repayable on the Maturity Date. The Company has the option to prepay the loans under the Blackstone Credit Facility in whole or in part, subject to early prepayment fees in an amount equal to (a) the greater of (i) the present value of the sum of (x) 3.00% of the principal amount to be prepaid as if that amount would otherwise be prepaid on the first anniversary of the Closing Date, and (y) the amount of all interest which would otherwise have accrued under the Amended Credit Agreement for the period from the date of such prepayment to the first anniversary of the Closing Date, assuming an interest rate for such period equal to the sum of the applicable margin for SOFR Loans plus Adjusted Term SOFR as of the date of determination, computed using a discount rate equal to the treasury rate as of such date plus 50 basis points (the “Make Whole Premium”) and (ii) 3.00% of the principal amount to be prepaid if prepayment occurs on or prior to the first anniversary of the Closing Date, (b) 3.00% of principal prepaid if prepayment occurs after the first anniversary of the Closing Date but on or prior to the second anniversary of the Closing Date, (c) 1.00% of principal prepaid if prepayment occurs after the second anniversary of the Closing Date and prior to or on the third anniversary of the Closing Date and (d) 0.00% after the date that is the third anniversary of the Closing Date. In addition, subject to the terms and conditions of the Amended Credit Agreement, the Company is required to make a mandatory prepayment of the term loans upon occurrence of certain events such as upon certain assets sales, events of loss, incurrence of debt not permitted to be incurred under the Amended Credit Agreement, or a change of control of our company.  
Interest rate SOFR     4.75%    
Debt instrument effective interest rate       9.62%  
Indebtedness to adjusted EBITDA ratio     5    
Blackstone Credit Facility | SOFR          
Subsequent Event [Line Items]          
Interest rate SOFR     2.00%    
Debt instrument effective interest rate     1.00%    
Interest rate margin increase     5.00%    
Blackstone Credit Facility | Additional Rate          
Subsequent Event [Line Items]          
Interest rate SOFR     3.00%    
Blackstone Credit Facility | Base Rate          
Subsequent Event [Line Items]          
Interest rate SOFR     3.75%    
Interest rate margin increase     4.00%    
Blackstone Credit Facility | On or Prior to First Anniversary of Closing Date          
Subsequent Event [Line Items]          
Additional interest rate on prepayment     3.00%    
Blackstone Credit Facility | After First Anniversary of Closing Date but on or Prior to Second Anniversary of Closing Date          
Subsequent Event [Line Items]          
Additional interest rate on prepayment     3.00%    
Blackstone Credit Facility | After second Anniversary of Closing Date and prior to or on Third Anniversary of Closing Date          
Subsequent Event [Line Items]          
Additional interest rate on prepayment     1.00%    
Blackstone Credit Facility | Term Loans          
Subsequent Event [Line Items]          
Term loan     $ 500.0    
Blackstone Credit Facility | Initial Term Loans          
Subsequent Event [Line Items]          
Term loan     75.0    
Blackstone Credit Facility | Delayed Draw Term Loan Commitments          
Subsequent Event [Line Items]          
Term loan     $ 125.0    
Option draw period     24 months    
Blackstone Credit Facility | Uncommitted Delayed Draw Term Loans          
Subsequent Event [Line Items]          
Term loan     $ 300.0    
Blackstone Credit Facility | scPharmaceuticals Inc.          
Subsequent Event [Line Items]          
Interest rate description       The term loans thereunder bear interest at a rate per annum equal to, (i) in the case of a Base Rate Loan, the greatest of (a) the prime rate in effect on such day, (b) the federal funds rate in effect on such day plus 0.5%, (c) Adjusted Term SOFR for a one-month’s tenor in effect on such day plus 1%, and (d) 3.0% plus a margin of 3.75%, or, (ii) in the case of a SOFR Loan, the one, three or six month term Adjusted Term SOFR (at the Company’s election), plus a margin of 4.75%. The interest rate margin increases to 4.00% in the case of a Base Rate Loan and 5.00% in the case of a SOFR Loan at any time the Company’s ratio of indebtedness to adjusted EBITDA (measured on a trailing four quarter basis) is greater than or equal to 5.00:1.00 as of the most recent fiscal quarter for which the Company has delivered financial statements. Following the draw of the delayed term loans on October 7, 2025, the SOFR Loans borrowed under the Blackstone Credit Facility will be subject to the Adjusted Term SOFR plus margin of 5.00% after the delivery of year-end financial statements. See Note 8 – Borrowings for additional discussion of the terms and conditions of the Blackstone Credit Facility.  
Blackstone Credit Facility | scPharmaceuticals Inc. | Subsequent Event          
Subsequent Event [Line Items]          
Borrowed amount to fund acquisition   $ 250.0      
Interest rate SOFR 5.00% 4.75%      
Debt instrument effective interest rate   0.50%      
Indebtedness to adjusted EBITDA ratio   5      
Blackstone Credit Facility | scPharmaceuticals Inc. | Subsequent Event | SOFR          
Subsequent Event [Line Items]          
Debt instrument effective interest rate   1.00%      
Interest rate margin increase   5.00%      
Blackstone Credit Facility | scPharmaceuticals Inc. | Subsequent Event | Additional Rate          
Subsequent Event [Line Items]          
Interest rate SOFR   3.00%      
Blackstone Credit Facility | scPharmaceuticals Inc. | Subsequent Event | Base Rate          
Subsequent Event [Line Items]          
Interest rate SOFR   3.75%      
Interest rate margin increase   4.00%